AND KLINIKA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 759,733 | 937,642 | 1,032,952 | 1,494,445 | 1,961,401 | 2,572,014 | 2,766,461 | 2,943,160 |
| Profit before tax | 32,449 | 68,790 | 157,377 | 195,882 | 213,140 | 167,734 | 150,533 | 123,696 |
| Net profit | 27,507 | 58,737 | 136,616 | 172,283 | 187,491 | 127,567 | 113,379 | 102,752 |
| Equity | 41,380 | 74,476 | 187,562 | 289,846 | 326,909 | 268,140 | 338,920 | 316,894 |
| Liabilities | 64,126 | 118,617 | 109,411 | 153,995 | 162,472 | 340,939 | 223,634 | 287,775 |
| Non-current assets | 62,705 | 100,358 | 74,807 | 62,407 | 41,302 | 265,361 | 339,513 | 347,002 |
| Current assets | 42,801 | 96,235 | 236,441 | 382,660 | 450,380 | 343,718 | 273,441 | 360,182 |
| Total assets | 105,506 | 196,593 | 311,248 | 445,067 | 491,682 | 609,079 | 612,954 | 707,184 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 356,918 | 399,497 | 433,275 |
| Social insurance contributions | - | - | - | - | - | 348,494 | 390,114 | 418,297 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +31.4% | +23.4% | +10.2% | +44.7% | +31.2% | +31.1% | +7.6% | +6.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 26.1% | 29.9% | 43.9% | 38.7% | 38.1% | 20.9% | 18.5% | 14.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 66.5% | 78.9% | 72.8% | 59.4% | 57.4% | 47.6% | 33.5% | 32.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.6% | 6.3% | 13.2% | 11.5% | 9.6% | 5.0% | 4.1% | 3.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 4.3% | 7.3% | 15.2% | 13.1% | 10.9% | 6.5% | 5.4% | 4.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.5 | 1.6 | 0.6 | 0.5 | 0.5 | 1.3 | 0.7 | 0.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 16,977 | 19,433 | 20,025 | 26,028 | 27,953 | 32,454 | 32,547 | 36,112 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
AND KLINIKA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-19 | 2026-07-21 | 205.90 |
| 2026-07-16 | 2026-07-17 | 205.90 |
| 2026-06-11 | 2026-06-11 | 0.02 |
| 2026-05-17 | 2026-06-08 | 0.02 |
| 2026-05-12 | 2026-05-13 | 0.02 |
| 2025-01-02 | 2025-01-09 | 37.27 |
| 2024-12-22 | 2024-12-31 | 37.27 |
| 2024-01-17 | 2024-01-21 | 14.56 |
| 2023-08-17 | 2023-09-11 | 0.30 |
| 2022-03-16 | 2022-04-10 | 0.01 |
| 2022-02-17 | 2022-03-08 | 0.01 |
| 2022-01-26 | 2022-02-08 | 0.01 |
AND KLINIKA - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-29 | 2025-07-25 | 3.35 |
| 2025-06-26 | 2025-06-26 | 242.06 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
AND KLINIKA, UAB (code 302690617) is a Private Limited Liability Company engaged in general medical practice activities. In 2025, revenue increased to €2.94M, up 6.4% year on year and 14.4% over two years, showing steady top-line expansion. Net profit declined to €102.8K from €113.4K in 2024 and €127.6K in 2023, while the profit margin narrowed from 5.0% in 2023 to 4.1% in 2024 and 3.5% in 2025. This indicates that profitability remained positive but softened as revenue grew. The balance sheet also expanded, with total assets rising to €707.2K in 2025 from €613.0K in 2024 and €609.1K in 2023. Equity stood at €316.9K and liabilities at €287.8K in 2025, compared with €338.9K and €223.6K a year earlier. Key ratios for 2025 show return on equity of 32.4%, return on assets of 14.5%, debt-to-equity of 0.91, and asset turnover of 4.16x. Revenue per employee was €36.3K, indicating measured productivity.